Semaglutide
The GLP-1 behind Wegovy® and Ozempic® — compounded, at a lower cash price.
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, supporting meaningful weight loss. The compounded form offers the same active molecule as Wegovy®/Ozempic® at a lower cash price for appropriate patients.
Prescription required. Final clinical decisions rest with the prescribing physician.
What is Semaglutide?
Semaglutide mimics the GLP-1 hormone to reduce appetite, increase fullness, and slow gastric emptying — the mechanism behind the strong weight-loss results seen with Wegovy® and Ozempic®. It’s dosed once weekly and titrated up over several weeks.
The compounded form is prepared by licensed compounding pharmacies and is not an FDA-approved finished product; availability can change with FDA guidance. The physician confirms candidacy and sets your titration.
Potential benefits
Proven GLP-1 mechanism
The same active molecule as Wegovy®/Ozempic®.
Appetite control
Reduces appetite and increases fullness.
Once-weekly
A single weekly injection, titrated gradually.
Lower cash price
A more affordable option than brand GLP-1 for appropriate patients.
How it works
How it’s taken
A once-weekly subcutaneous injection, titrated up over several weeks to limit side effects. The physician sets your schedule.
Typical protocol
Gradual dose escalation to a maintenance dose, with check-ins on progress and tolerability.
How ordering works
Complete the intake
Share your goals, health history, and current medications — about 5 minutes.
Physician evaluation
An independent, board-certified physician reviews your intake and, if appropriate, prescribes Semaglutide with a dosing protocol.
Compounded & shipped
The prescription is filled by a licensed compounding pharmacy and shipped to your door with instructions.
What to know before Semaglutide
Semaglutide is a bioactive compound. The physician you’re connected with will review the relevant risks and contraindications for your situation before prescribing.
- •Common side effects are nausea, and other GI effects, usually easing as the dose is titrated.
- •Not for personal/family history of medullary thyroid carcinoma or MEN 2, or with certain GI conditions.
- •Disclose your full history and current medications; the physician confirms candidacy.
- •Compounded semaglutide is not an FDA-approved finished product; availability can change with FDA guidance.
Semaglutide FAQ
Is compounded semaglutide the same as Wegovy/Ozempic?
It’s the same active molecule (semaglutide), prepared by a compounding pharmacy rather than the brand manufacturer — typically at a lower cash price.
How is it taken?
A once-weekly subcutaneous injection, titrated up gradually; the physician sets your dosing.
Is it FDA-approved?
Brand semaglutide is FDA-approved; the compounded form is not a finished FDA-approved product and is prescribed under physician supervision. Availability can change with FDA guidance.
How much weight will I lose?
Results vary; trials of semaglutide show significant average weight loss. The physician sets realistic expectations for you.
How much does it cost?
Compounded semaglutide starts from $169/month. Final pricing is confirmed after your physician evaluation. The initial evaluation is free.
Ready to start Semaglutide?
Complete a short medical intake — a supervising physician reviews it and, if appropriate, writes your prescription, and a licensed pharmacy ships to your door.
Pricing & regulatory note: The $169/mo price is an indicative starting point confirmed by the compounding pharmacy after physician evaluation. Semaglutide is not an FDA-approved finished drug product; it is prepared by licensed compounding pharmacies and prescribed off-label. FDA guidance on peptide compounding continues to evolve and availability can change. A prescription is required.